GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancerQin Wu, C.H. Arrowsmith, Wail Ba-Alawi et al.|Nature Communications|2020Cited by 307
Preclinical target validation using patient-derived cellsA.M. Edwards, Kevin Petrecca, Dhavalkumar D. Patel et al.|Nature Reviews Drug Discovery|2015Cited by 55
GLUT1 inhibition blocks growth of RB1-positive Triple Negative Breast CancerQin Wu, C.H. Arrowsmith, Wail Ba-Alawi et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 19